Evidence map›Paper›PMID 27102866›Full record

ArticleScientific reports2016

Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses.

Vilma Aho, Hanna M Ollila, Erkki Kronholm, Isabel Bondia-Pons, Pasi Soininen, Antti J Kangas, Mika Hilvo, Ilkka Seppälä, Johannes Kettunen, Mervi Oikonen and 16 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A [Journal of neuroinflammation · 2025
    Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 16 institutions in 3 countries.

Vilma AhoDepartment of Physiology, Faculty of Medicine, University of Helsinki, Finland.
Hanna M OllilaDepartment of Physiology, Faculty of Medicine, University of Helsinki, Finland.
Erkki KronholmDepartment of Chronic Disease Prevention, Population Studies Unit, National Institute for Health and Welfare, Turku, Finland.
Isabel Bondia-PonsVTT Technical Research Centre of Finland, Espoo, Finland.
Pasi SoininenComputational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland.
Antti J KangasComputational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland.
Mika HilvoVTT Technical Research Centre of Finland, Espoo, Finland.
Ilkka SeppäläDepartment of Clinical Chemistry, Fimlab Laboratories, and University of Tampere, School of Medicine, Tampere, Finland.
Johannes KettunenGenomics and Biomarkers unit and Institute for Molecular Medicine FIMM, National Institute for Health and Welfare, Helsinki, Finland.
Mervi OikonenResearch Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
Emma RaitoharjuDepartment of Clinical Chemistry, Fimlab Laboratories, and University of Tampere, School of Medicine, Tampere, Finland.
Tuulia HyötyläinenVTT Technical Research Centre of Finland, Espoo, Finland.
Mika KähönenDepartment of Clinical Physiology, University of Tampere and Tampere University Hospital, Tampere, Finland.
Jorma S A ViikariDepartment of Medicine, University of Turku, and Division of Medicine, Turku University Hospital, Turku, Finland.
Mikko HärmäBrain and Work Research Centre, Finnish Institute of Occupational Health, Helsinki, Finland.
Mikael SallinenBrain and Work Research Centre, Finnish Institute of Occupational Health, Helsinki, Finland.
Vesa M OlkkonenMinerva Foundation Institute for Medical Research, Helsinki, Finland.
Harri AleniusUnit of Excellence for Immunotoxicology, Finnish Institute of Occupational Health, Helsinki, Finland.
Matti JauhiainenGenomics and Biomarkers unit and Institute for Molecular Medicine FIMM, National Institute for Health and Welfare, Helsinki, Finland.
Tiina PaunioGenomics and Biomarkers unit and Institute for Molecular Medicine FIMM, National Institute for Health and Welfare, Helsinki, Finland.
Terho LehtimäkiDepartment of Clinical Chemistry, Fimlab Laboratories, and University of Tampere, School of Medicine, Tampere, Finland.
Veikko SalomaaDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Matej OrešičVTT Technical Research Centre of Finland, Espoo, Finland.
Olli T RaitakariResearch Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
Mika Ala-KorpelaComputational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland.
Tarja Porkka-HeiskanenDepartment of Physiology, Faculty of Medicine, University of Helsinki, Finland.
Institute for Molecular Medicine Finland · FIFimlab (Finland) · FIFinnish Institute for Health and Welfare · FIFinnish Institute of Occupational Health · FISteno Diabetes Center · DKUniversity of Helsinki · FIUniversity of Oulu · FIUniversity of Turku · FIVTT Technical Research Centre of Finland · FIHelsinki University Hospital · FIMinerva Foundation · FITampere University · FITampere University Hospital · FITurku University Hospital · FIUniversity of Eastern Finland · FIUniversity of Jyväskylä · FI

Funding

Medical Research Council MC_UU_12013/1
6 · The paper itself

Abstract

Sleep loss and insufficient sleep are risk factors for cardiometabolic diseases, but data on how insufficient sleep contributes to these diseases are scarce. These questions were addressed using two approaches: an experimental, partial sleep restriction study (14 cases and 7 control subjects) with objective verification of sleep amount, and two independent epidemiological cohorts (altogether 2739 individuals) with questions of sleep insufficiency. In both approaches, blood transcriptome and serum metabolome were analysed. Sleep loss decreased the expression of genes encoding cholesterol transporters and increased expression in pathways involved in inflammatory responses in both paradigms. Metabolomic analyses revealed lower circulating large HDL in the population cohorts among subjects reporting insufficient sleep, while circulating LDL decreased in the experimental sleep restriction study. These findings suggest that prolonged sleep deprivation modifies inflammatory and cholesterol pathways at the level of gene expression and serum lipoproteins, inducing changes toward potentially higher risk for cardiometabolic diseases.

Indexed as

AdultAgedBlood Chemical AnalysisCholesterolFemaleFinlandGene Expression ProfilingHumansInflammationMaleMetabolic DiseasesMetabolomeMiddle AgedSleep DeprivationCholesterol

Identifiers

PMID27102866
PMCPMC4840329
OpenAlexW2342297585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.